Stock listing

STIM Stock Price, News, Filings & Events — Neuronetics, Inc.

Selected listing: STIM · BOATS · USD · US

This page tracks Neuronetics, Inc.'s STIM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following STIM:BOATS. STIM:BOATS is the stock-level entry point for investors researching Neuronetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neuronetics, Inc. is a publicly traded company in the American market, listed under the ticker STIM. The company has a market capitalization of approximately $112.7 million. Neuronetics focuses on developing innovative treatments for mental health conditions.

STIM:BOATSUSDUSUpdated September 4, 2026
Neuronetics, Inc. logo
Ticker
STIM:BOATS
Asset type
Stock
Market cap
$219.4M
Sector
Health Technology
Industry
Medical Specialties
Exchange
BOATS
Currency
USD

Neuronetics, Inc. STIM:BOATS stock context

This page tracks Neuronetics, Inc.'s STIM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following STIM:BOATS. STIM:BOATS is the stock-level entry point for investors researching Neuronetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neuronetics, Inc. is a publicly traded company in the American market, listed under the ticker STIM. The company has a market capitalization of approximately $112.7 million. Neuronetics focuses on developing innovative treatments for mental health conditions.

Latest news from Neuronetics, Inc.

All Neuronetics, Inc. news →

Neuronetics, Inc. earnings calls

Research Neuronetics, Inc.

Alternate listings